SHL Overzicht aandelen
Siemens Healthineers AG ontwikkelt, produceert en verkoopt via zijn dochterondernemingen een reeks diagnostische en therapeutische producten en diensten aan zorgverleners over de hele wereld. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 2/6 |
| Dividenden | 3/6 |
Siemens Healthineers AG Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | €49.80 |
| 52 Week Hoogtepunt | €58.14 |
| 52 Week Laag | €47.31 |
| Bèta | 0.73 |
| 11 maand verandering | -2.96% |
| 3 maanden verandering | -2.62% |
| 1 Jaar Verandering | -3.26% |
| 33 jaar verandering | -21.57% |
| 5 jaar verandering | 13.13% |
| Verandering sinds IPO | 64.90% |
Recent nieuws en updates
Siemens Healthineers AG (ETR:SHL) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Nov 10
Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Recent updates
Siemens Healthineers AG (ETR:SHL) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Nov 10Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Rendement voor aandeelhouders
| SHL | DE Medical Equipment | DE Markt | |
|---|---|---|---|
| 7D | -0.8% | -1.0% | -0.02% |
| 1Y | -3.3% | -7.3% | 8.2% |
Rendement versus industrie: SHL overtrof de German Medical Equipment industrie, die het afgelopen jaar een rendement -7.3 % opleverde.
Rendement versus markt: SHL presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 8.2 % opleverde.
Prijsvolatiliteit
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stabiele aandelenkoers: SHL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van SHL is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| n/a | 72,300 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG ontwikkelt, produceert en verkoopt via haar dochterondernemingen een reeks diagnostische en therapeutische producten en diensten aan zorgverleners wereldwijd. Het bedrijf is actief in vier segmenten: Imaging, Diagnostics, Varian en Advanced Therapies. Het segment Imaging levert magnetische resonantiebeeldvorming, computertomografie, röntgensystemen, moleculaire beeldvorming en ultrasone systemen.
Siemens Healthineers AG Samenvatting
| SHL fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €55.57b |
| Inkomsten(TTM) | €1.94b |
| Inkomsten(TTM) | €22.36b |
28.6x
Koers/Winstverhouding2.5x
P/S-verhoudingIs SHL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| SHL resultatenrekening (TTM) | |
|---|---|
| Inkomsten | €22.36b |
| Kosten van inkomsten | €13.90b |
| Brutowinst | €8.47b |
| Overige uitgaven | €6.53b |
| Inkomsten | €1.94b |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
Nov 26, 2024
| Winst per aandeel (EPS) | 1.74 |
| Brutomarge | 37.87% |
| Nettowinstmarge | 8.68% |
| Schuld/Eigen Vermogen Verhouding | 89.0% |
Hoe presteerde SHL op de lange termijn?
Bekijk historische prestaties en vergelijking